A European technology group identified a mid-market acquisition target in Hong Kong. The deal had clear commercial logic. Yet within weeks of signing heads of terms, the client discovered that regulatory conditions – spanning competition legislation, securities regulation, and corporate formalities – threatened both the timeline and the commercial value of the transaction.
M&A transactions in Hong Kong require coordinated management of competition clearance under competition legislation, securities regulatory review by the Securities and Futures Commission (SFC), and registration of corporate changes with the Companies Registry Hong Kong. A well-structured share purchase agreement with carefully drafted closing conditions determines whether the deal closes on schedule or stalls at a regulatory gate. The process from signed heads of terms to completion typically spans three to six months for cross-border transactions with regulatory dimensions.
This case study examines how Ferraz & Whitmore supported the client through each phase, the complications that arose mid-process, and the transferable lessons relevant to any cross-border M&A matter in Hong Kong.
Client profile and the challenge at hand
The client was a European-headquartered technology group with existing operations across Asia-Pacific. It sought to acquire a controlling stake in a Hong Kong-incorporated software business serving regulated financial institutions.
Two factors made the deal structurally sensitive. First, the target held licensing relationships with counterparties regulated by the SFC. A change of control in the target therefore triggered notification obligations under securities legislation. Second, the combined market position of the acquirer and target in one product segment met the threshold for review under Hong Kong's competition legislation.
The client's in-house team had handled acquisitions in common law jurisdictions before. However, they had not previously worked through the specific interaction between Hong Kong's competition regime and its securities regulatory environment. Both can independently delay or condition a closing. When they arise together, sequencing becomes critical.
The immediate risk was straightforward: each week of delay increased the probability that a key employee. identified during due diligence as central to the target's client relationships. would exercise exit rights triggered by the prolonged uncertainty. Losing that individual before closing would materially reduce the target's value. The client needed a sequenced strategy, not a parallel filing approach.
Legal strategy: sequencing, structure, and the share purchase agreement
The first strategic decision was to structure the transaction as a share acquisition rather than an asset purchase. Under Hong Kong corporate legislation, a share acquisition preserves existing regulatory licences held by the target entity. An asset purchase would have required fresh applications to the SFC for each regulated licence – adding months to the timeline.
The share purchase agreement (SPA) was drafted with closing conditions that reflected the regulatory sequencing precisely. Three conditions were designated as non-waivable: competition clearance, SFC notification acknowledgement, and completion of Companies Registry Hong Kong filings for the new directors. Two further conditions – relating to third-party contractual consents – were designated as waivable by mutual agreement after a specified longstop date.
This distinction mattered commercially. Non-waivable conditions prevent either party from being forced to close while a regulatory issue remains open. Waivable conditions preserve flexibility when a minor consent is delayed by an unresponsive counterparty rather than a genuine legal obstacle.
The representations and warranties in the SPA were drafted with particular attention to the target's regulatory status. The seller gave specific representations and warranties confirming that no SFC enforcement action was pending or threatened. That all competition legislation compliance obligations had been met in the prior three years. Additionally, that no material contracts contained change-of-control provisions that had not been disclosed in due diligence.
An escrow mechanism was included in the payment structure. A portion of the purchase price was held in escrow for eighteen months post-closing, available to the buyer as a remedy for warranty breaches identified after completion. This is a standard instrument in Hong Kong M&A practice, but the allocation between escrow and deferred consideration was negotiated carefully given the seller's liquidity requirements.
For clients engaged in M&A transactions in Hong Kong, the interaction between the SPA closing conditions and regulatory filing timelines is one of the most consequential drafting decisions in the entire deal.
Key milestones and complications encountered
The transaction proceeded through four main phases. Each produced at least one complication that required active management.
Phase one – due diligence and pre-filing analysis (weeks one to six). The due diligence exercise identified two issues not disclosed in the data room. One historical contract contained a change-of-control clause that had not been flagged by the target's own management. The clause gave a key client the right to terminate on thirty days' notice following a change of control. The second issue was a minor filing irregularity at the Companies Registry Hong Kong relating to a previous directorship change. Neither issue was transaction-blocking, but both required immediate action – direct client engagement to waive the termination right, and a corrective filing with the Companies Registry before the acquisition filing was submitted.
Phase two – competition filing (weeks five to fourteen). The merger notification was filed under Hong Kong's competition legislation. The review process involved a written submission and two rounds of information requests from the relevant authority. The authority's questions focused on the combined market share in one software product category and the barriers to entry for competing products. The analysis submitted demonstrated that barriers to entry were low and that multiple competing products were available to regulated financial institutions. Clearance was granted conditionally, with a behavioural condition requiring the combined entity to maintain interoperability with specified third-party systems for three years post-closing. This condition was within the client's operational capacity and did not threaten the commercial rationale.
Phase three – SFC notification (weeks eight to fifteen). The SFC notification process ran in parallel with the later stages of the competition review. Under securities legislation, a change of control affecting an entity with licensed relationships requires advance notification and a period for the SFC to raise objections. No objection was raised, but the SFC requested supplementary information about the acquirer's group structure and its existing regulatory status in other jurisdictions. Providing that information accurately and promptly – without raising new questions – required close coordination between the Hong Kong filing and the client's European group counsel.
Phase four – closing (week sixteen). All non-waivable conditions had been satisfied. The two waivable conditions relating to third-party consents were waived by mutual agreement after the longstop date passed without resolution. Closing formalities were completed, new directors were registered at the Companies Registry, and the escrow account was funded. The key employee identified during due diligence remained in post and subsequently became part of the retention programme negotiated as a pre-closing covenant.
The most significant complication across all phases was the information request from the SFC. It arrived during a period when the competition clearance was still pending. Had the SFC raised an objection – rather than a supplementary information request – the sequencing would have required reconsideration. The client had been advised at the outset that this scenario was possible. Having a contingency position prepared in advance meant the team could respond to the information request within five business days rather than requesting an extension.
Practitioners advising on cross-border M&A in Hong Kong consistently note that regulatory processes rarely proceed exactly as projected. The value of preparation lies not in predicting which complication will arise, but in having a documented response plan when it does.
For comparable considerations in a different high-growth market, the lessons from the M&A transaction case study for the UAE illustrate how regulatory sequencing challenges arise across different legal systems.
To explore a tailored strategy for your M&A transaction in Hong Kong, contact us at info@ferrazwhitmore.com.
Three transferable lessons for cross-border M&A in Hong Kong
Lesson one: closing conditions must reflect regulatory sequencing, not just regulatory existence. Many cross-border SPAs list regulatory approvals as closing conditions without specifying the order in which those conditions must be satisfied. In Hong Kong transactions involving both competition legislation and securities legislation, the two regulatory processes have different timelines and different consequences if they overlap. The SPA should specify which condition must be satisfied first and what happens if the second condition produces an unexpected objection after the first has been cleared. Failing to address this creates leverage uncertainty for both parties.
Lesson two: due diligence in Hong Kong must go beyond the data room. The two issues identified in this matter. the undisclosed change-of-control clause and the Companies Registry irregularity. were not visible in the documents provided by the target. They required direct searches at the Companies Registry Hong Kong and independent review of the target's material contracts against publicly available counterparty information. International buyers accustomed to data-room-only due diligence processes frequently miss issues of this kind. The cost of identifying them before filing is a fraction of the cost of discovering them after closing, when warranty claims become the only remedy.
Lesson three: the Hong Kong International Arbitration Centre (HKIAC) clause is not a formality. The SPA in this matter included an HKIAC arbitration clause with Hong Kong as the seat. Post-closing, a minor warranty dispute arose relating to the pre-closing period. Because the dispute resolution clause was clearly drafted – specifying the number of arbitrators, the language, and the applicable rules – the matter was resolved through a single-arbitrator expedited procedure in under three months. Buyers and sellers who treat the arbitration clause as boilerplate frequently discover at the point of dispute that ambiguities in the clause itself become the first contested issue. The Hong Kong High Court has consistently upheld well-drafted HKIAC clauses and supported the enforcement of resulting awards, which makes Hong Kong a reliable seat for cross-border M&A disputes in the Asia-Pacific region.
The broader principle across all three lessons is that lost opportunity in cross-border M&A rarely announces itself in advance. It tends to materialise as a regulatory delay that erodes commercial value, a contractual ambiguity that lengthens a post-closing dispute, or a due diligence gap that surfaces as a warranty claim. Each of these is avoidable with the right preparation. Engaging a lawyer in Hong Kong with cross-border M&A experience – and with direct knowledge of how the SFC, Companies Registry Hong Kong, and competition authorities interact – substantially reduces exposure to each category.
The corporate law practice in Hong Kong at Ferraz & Whitmore supports clients through the full transaction lifecycle, from initial structuring through to post-closing integration and dispute resolution.
To discuss how the regulatory conditions and competition clearance process applies to your specific transaction, reach out to info@ferrazwhitmore.com.
About Ferraz & Whitmore
Ferraz & Whitmore is an international law firm based in Lisbon, advising business clients across 46 jurisdictions. Our team combines Portuguese civil law expertise with English common law tradition to deliver cross-border legal solutions in M&A transactions. This includes share purchase agreement drafting. Due diligence, regulatory clearance. Additionally, post-closing dispute resolution in Hong Kong and across Asia-Pacific. We work with international acquirers, institutional investors, and in-house legal teams who require results-oriented counsel capable of managing multiple regulatory processes simultaneously. Our Asia-Pacific M&A practice includes practitioners with experience before the HKIAC and with direct engagement with the SFC and Companies Registry Hong Kong. The firm's Lisbon base provides direct access to EU regulatory systems, while our common law expertise supports enforcement and arbitration strategies across English-speaking jurisdictions. As a law firm in Hong Kong matters, we coordinate local regulatory filings with the broader cross-border deal structure from day one. To discuss your M&A transaction in Hong Kong, contact us at info@ferrazwhitmore.com.
Disclaimer: This publication is provided for informational purposes only and does not constitute legal advice. The information herein should not be relied upon as a substitute for professional legal counsel tailored to your specific circumstances. Ferraz & Whitmore assumes no liability for actions taken or not taken based on the contents of this material. For advice regarding your particular situation, please contact info@ferrazwhitmore.com.